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http://intl.elsevierhealth.com/journals/ijidTable 1 HAV infection prevalence rates
1998—2002 (n = 1692) 2003—2007 (n = 726)
HAV
IgG (+)
HAV
IgG ()
HAV
IgG (+)
HAV
IgG ()
Females 326 486 208 176
Males 378 502 186 156
Total 704 (42%) 988 (58%) 394 (54%) 332 (46%)
HAV, hepatitis A virus.Changes in hepatitis A prevalence rates be-
tween 1998 and 2007 in Eskisehir, Turkey
Hepatitis A virus (HAV) is generally transmitted by the
fecal—oral route and is one of the most frequent causes
of viral hepatitis throughout the world. The Turkish sero-
prevalence rates of HAV infection are known to correlate
with those of other developing countries. In various studies
in Turkey 40% positivity has been reported in children aged
0—10 years, and in those aged over 15 years the rates are
around 90%.1
Our study, which covered the period 1998—2007,
was carried out in the Eskisehir Military Hospital and
included non-vaccinated individuals without icterus and
with median incomes. Serum samples were tested by
ELISA. Chi-square tests were used in the statistical ana-
lyses.
A total of 2418 applicants with an average age of 19.5
years (852 females (average age 17.7 years) and 1568 males
(average age 21.4 years)) were tested for anti-HAV IgG. The
results were evaluated for two time periods. The first group
included the years 1998—2002 and the second group the years
2003—2007. The results are presented in Table 1. In the
statistical analyses, an increase in the prevalence between
the two periods was found ( p < 0.001). The same correlation
was seen for both genders, with an increase for anti-HAV IgG
positivity and a decrease for anti-HAV IgG negativity
( p < 0.001).
These results can be explained by the inadequate vacci-
nation of the population. Since HAV vaccination is not
included in the official schedule in Turkey, increasing public
awareness should be the focus of interest.
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